WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the creation of its new Scientific Advisory Board (SAB), marking a strategic step in advancing its focus on immuno-inflammatory ...
Some results have been hidden because they may be inaccessible to you